Novel Angiogenic Signaling Pathways and Vascular Targets
- 10 February 2004
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 44 (1) , 219-238
- https://doi.org/10.1146/annurev.pharmtox.44.101802.121650
Abstract
Intense investigation into the molecular basis of angiogenesis is rapidly revealing novel signaling pathways involved in the generation of new vasculature. These range from elucidation of the mechanism by which hypoxia initiates expression of a proangiogenic gene repertoire via the hypoxia-inducible transcription factors (HIFs) to molecular pathways involved in extra- and intracellular signaling during new vessel formation. Extracellular pathways include those of the Notch/delta, ephrin/Eph receptor and roundabout/slit families, and intracellular pathway members of the hedgehog and sprouty families. The involvement of these pathways in angiogenesis is discussed, together with some comments on recently identified targets in the vasculature that present new therapeutic opportunities.Keywords
This publication has 93 references indexed in Scilit:
- Transcriptional Activation of the Human Leptin Gene in Response to HypoxiaJournal of Biological Chemistry, 2002
- Identification and Molecular Characterization of Two Closely Related G Protein-coupled Receptors Activated by Prokineticins/Endocrine Gland Vascular Endothelial Growth FactorJournal of Biological Chemistry, 2002
- Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptorsBiochemical and Biophysical Research Communications, 2002
- Specialization of tumour vasculatureNature Reviews Cancer, 2002
- VEGF165 mediates formation of complexes containing VEGFR‐2 and neuropilin‐1 that enhance VEGF165‐receptor bindingJournal of Cellular Biochemistry, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapyGene Therapy, 2001
- Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblastsInternational Journal of Gynecologic Cancer, 2001
- The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularizationOncogene, 2000
- Repulsive Axon GuidanceCell, 2000